Alasdair qualified from Cambridge in 1990. After graduation, he joined Bristol Vet School, first as an intern and then as a resident.
He then became a Lecturer and Senior Clinical Fellow in small animal surgery at Langford from 1997 to 2009.
He was also the Programme Director of the veterinary nursing degree and led years 3-5 of the BVSc programme.
He then moved to private practice, becoming Head of Referral Surgery at Bath Vet Referrals, and then Group Veterinary Advisor and member of the Clinical Advisory Board when it was acquired by IVC, after which he moved to Vale Referrals.
He received his Fellowship for Contributions to Clinical Practice in 2017 and is an Advanced Practitioner in Small Animal Surgery.
Alasdair will mainly be helping to develop Brains & Drains, a new library of peer-reviewed clinical demonstrations published on YouTube for the benefit of practitioners around the world.
He’ll also be helping to steer the development of other content on VetSurgeon.org and VetNurse.co.uk
Publishing Editor Arlo Guthrie said: “Alasdair and I first collaborated nine years ago to make a film called: Total Ear Canal Ablation and Lateral Bulla Osteotomy.
"Who’d have that would be such a box office hit, with over 90,000 views on Facebook!
“Now we’re stepping up production, both by filming our own content and inviting all vets and nurses to film demonstrations themselves and submit them for peer review.”
Arlo added: “In recent years, there's been an explosion in the number of social media groups for the veterinary profession, primarily on Facebook and Instagram, which has led to a real fragmentation.
It’s as yet unclear whether that'll always be the case. Certainly young people are already migrating elsewhere, both because it’s not very hip to be on the same platform as your parents, and also a growing awareness of some of the harms of Facebook on mental health."
“Either way, with so much fragmentation, it is clear we need to offer more by way of quality content on VetSurgeon.org than we have in the past, and I’m really excited to be working alongside Alasdair to do just that, so that whatever the ups and downs of other social media, VetSurgeon and VetNurse remain reliable, transparent places for good quality information sharing.”
Boehringer Ingelheim Vetmedica has launched Semintra, a new liquid treatment for cats with chronic kidney disease (CKD).
The active ingredient in Semintra is telmisartan, the first angiotensin receptor blocker to be licensed in veterinary medicine.
Like benazepril, Semintra is indicated for the reduction of proteinuria associated with CKD in cats. Boehringer says it has a highly targeted mode of action that provides rapid and reliable reduction of proteinuria in cats with chronic kidney disease. The company adds that it is well tolerated and almost exclusively excreted in the faeces, so elimination is not dependent on renal function.2
Above all, Boehringer is highlighting the how easy the treatment is to use, pointing to a study that has shown it is well accepted by more than 90% of cats.1,3
Martha Cannon, RCVS Specialist in Feline Medicine at the Oxford Cat Clinic, has already used Semintra in cats with CKD. She said: "For us at the Oxford Cat Clinic, ease of use is an enormously important part of any product that we use for cats. From our personal experience, we found that Semintra is very well accepted by cats, with owners finding it very easy to give and to build into their cat's daily treatment plan."
Semintra is available from veterinary wholesalers as a 4mg/ml oral solution. There is one 30 ml bottle size which will last the average 4kg cat 30 days.
A few CKD facts provided by Boehringer:
For further information on Semintra visit www.semintra.co.uk, contact your local Boehringer Ingelheim territory manager or telephone +44 (0)1344 746959.
References
Bell Equine is one of the leading equine hospitals and was the first practice worldwide to install a standing MRI unit for horses.
CVS says the acquisition reflects its increased focus on equine practice, with further expansion of its Equine Division planned in the UK and Europe during 2017.
Equine Director Ben Jacklin said: "The acquisition of such an outstanding hospital is an exciting step for us. Bell Equine has always been at the forefront of the equine profession, both clinically and non-clinically, and as such it is a perfect match for the Equine Division of CVS."
Julian Samuelson, former managing director of Bell Equine, will continue in the role of Clinical Director. He said: "We are delighted to be joining forces with CVS and are very much looking forward to working closely with the Group to help realise the exciting potential of its equine ambitions. We look forward to the opportunity to continue to lead the profession, both within and outside CVS."
The London Vet Show will next take place on 11th and 12th November 2021 at the ExCeL Center, London.
CloserStill says the decision to cancel was made following several discussions with industry stakeholders, including partners, and considering the significant impact of both international and domestic travel.
Rob Chapman, MD of CloserStill’s veterinary portfolio, said: "COVID-19 has brought enormous pressures and uncertainty to the veterinary sector - both personally and professionally.
"Although the UK Government gave the green light for exhibitions and meetings to start again in October, after examining at the overall market and consultation with our partners, we feel the decision to postpone is in the best interest of the veterinary community.
"Although this news may be disappointing to those looking forward to the London Vet Show, unfortunately the coronavirus situation is continually developing. We want to be as clear and upfront as possible with our community and customers, and after careful consideration, our decision to reschedule was out of caution. As event organisers, the health and safety of our exhibitors, delegates, speakers, staff and supporters, is our number one priority."
"Obviously the postponement decision hasn’t been easy but we firmly believe it’s the right thing to do. We are so fortunate to have support of great partners like the Royal Veterinary College and the British Veterinary Association, along with the exhibitors, speakers and delegates we’ve spoken to so far; everyone has been really understanding. We can’t wait to see you all again virtually soon, and in person in 2021."
"The team and I are eager to continue to provide world-class education to veterinary professionals, to connect and encourage networking to foster the advancement of the veterinary sector. We are developing some great opportunities for the veterinary community come November. We will be announcing more details on this very soon."
The company says the masterclass will equip veterinary surgeons with an understanding of how TPLO fits into the range of treatments for one of the commonest causes of serious hindlimb lameness in the adult dog: cranial cruciate ligament failure.
The course will take place on 13 and 14 September at Improve’s HQ, Alexandra House, Swindon, and will be led by Dr Steve Butterworth, MA VetMB CertVR DSAO MRCVS and RCVS Specialist in Small Animal Surgery (Orthopaedics).
Improve’s Veterinary Operations Manager Juliet Pope MRCVS, said: "We are delighted to offer this new masterclass, created for a maximum of ten delegates to ensure true one-to-one tutoring, and we thank the team at Freelance Surgical for supporting its development.
"The combination of lectures and practical sessions led by Steve Butterworth will revise relevant surgical anatomy to enable delegates to undertake TPLO procedures with confidence. We are particularly pleased to be able to offer radiography as an integral part of the course so that delegates can see the results of their new surgical skills before taking them back to their clinics."
The initiative will run until early 2019, and has been expanded to include cats as well as dogs. In the run up, Lintbells is also offering lunch and learn sessions to help practices implement the clinics.
The company reports that feedback from 50 veterinary surgeons, nurses and practice managers who took part in the initiative last year was encouragingly positive. 86% agreed or strongly agreed that they are now managing mobility issues more effectively in practice and 90% thought client compliance had increased.
96% said they thought vets, nurses and reception staff were communicating more effectively. 95% thought the training had improved staff morale. 94% of veterinary staff felt clients were more confident about managing their pet’s condition and 92% thought more mobility issues had been identified. 74% said they thought practice revenue had increased.
Lintbells Brand Manager, Gemma Cunningham said: "We’re really pleased to be able to help practices to provide support for pets with stiff joints. This year we’ve made some exciting additions to the practice pack based on our ongoing conversations and feedback. Mobility issues in cats are often overlooked and we want to raise awareness and help support owners. By including cats this time round we hope to assist practices with their efforts to encourage cat owners to have their less active and sedentary cats checked out."
Practices that want to register an interest in receiving a Mobility Matters pack can contact their local Lintbells Veterinary Business Development Executive or visit www.lintbellsvet.com.
The Disciplinary Committee heard that Miss Oakes had signed a Greyhound Board of Great Britain (GBGB) Veterinary Surgeons Residential Kennel Inspection Form which indicated that there were 55 greyhounds in the kennel, when there were in fact more; that she had stated that the kennels were in an acceptable condition, when they were in fact not; and that she knew the form was inaccurate and/or was dishonest in relation to what she had indicated on the form.
The kennels in question, Rough Cottage, were owned by Louise Eccles and her husband, Rod Eccles. Mrs Eccles was licensed by GBGB as a trainer, allowing her to train and race greyhounds and making the kennels accountable to inspections by veterinary surgeons.
At the time of the form in question, Miss Oakes had been attending Rough Cottage for about a year-and-a-half on a monthly basis, up through August 2016. At that point, on or around 1 August 2016, Mrs Eccles had left Rough Cottage for personal reasons.
Miss Oakes subsequently visited the premises on 14 August 2016 along with Amanda Gething of Northern Greyhound Rescue, when she learned that rather than there being 55 dogs, there were more than 80.
On 16 August, she and Amanda Gething returned to Rough Cottage with Lucille Cavadino, from Lancky Dogs, a greyhound rescue organisation. They became aware of the existence of kennels on the premises that were not of acceptable standard, but Miss Oakes found that the dogs housed in these kennels were fit and healthy.
Miss Oakes also spoke to Mr Eccles around this time, and although he had plans to rehouse some of the dogs she was concerned that he might change his mind. Miss Oakes took the decision to complete and sign the kennel inspection form that Mr Eccles had handed to her, knowing that the details contained therein were incorrect. She stated that the reason that she did this was to appease Mr Eccles so that he would not hinder the plans to remove and rehouse the dogs. She admitted to the area GBGB Stipendiary Steward that she had signed the form and that it contained incorrect information.
At the beginning of the hearing Miss Oakes admitted all the charges except for the final one, namely that she had been dishonest about what she had indicated on the form. When she gave evidence during the hearing, however, she admitted that she had been dishonest and so all charges were found proved.
The Committee then turned to deciding whether these charges, having been found proven, would result in a finding of disgraceful conduct in a professional respect against Miss Oakes. The Committee considered her motives in signing the form were to try and safeguard animal welfare, but considered that she was misguided in how she chose to achieve that aim. The Committee, therefore, found that signing a form that is known to be misleading or inaccurate is in definite breach of the Code of Professional Conduct, and concluded that her conduct constituted disgraceful conduct in a professional respect.
When considering a suitable sanction, the Committee took into account a number of mitigating factors, including some 62 testimonials that were submitted in favour of Miss Oakes, and the fact that she believed she was acting in the best interests of the animals’ welfare.
Chitra Karve, Chair of the Disciplinary Committee, said: "So far as mitigating factors are concerned, the Committee is satisfied that the Respondent’s motivation for what she did was governed by her overwhelming wish to promote the health or welfare of the greyhounds at Rough Cottage.
"The Committee is satisfied that no actual harm or risk of harm to any animal occurred in this case. There was no financial gain to the Respondent and the Committee has been told that she charged no fee for her extensive efforts in organising or assisting with the removal and rehousing of the greyhounds from Rough Cottage.
"The Committee considers that this was a single and isolated incident and that the risks of similar behaviour being repeated in the future are low."
Chitra added: "The Committee has decided that it will be sufficient to protect the welfare of animals, to maintain public confidence in the profession and to declare and uphold proper standards of conduct, for the Respondent to be given a formal warning as to her future conduct."
All jobs posted on VetNurse.co.uk are valid for 60 days (double that normally offered elsewhere). They are also emailed automatically to any subscribers with matching search criteria, fed out onto Facebook and the like, and optimised for Google For Jobs.
To post an advert for a veterinary nurse, register on www.vetnurse.co.uk, login and visit: https://www.vetnurse.co.uk/veterinary-jobs/.
Alternatively, if your practice is looking for a veterinary nurse, do share this with the practice owner or manager.
The gilets, which normally cost $170, have three heating zones: one around the neck, one across the back of the shoulders and one which heats the pockets, all powered by a small battery.
VetSurgeon Editor Arlo Guthrie (pictured right) said: "As some members will know, I have a sideline reviewing gadgets and consumer tech on YouTube. Having reviewed the Ororo gilet, I bought a number of them for myself and my family, but thanks to a mix up by Amazon, I ended up with a spare men's XL size gilet (45-48 inch chest, 40-43 inch waist and 46-49 inch hip) .
"I'd like it to go to a good home, and I thought maybe a veterinary surgeon or nurse who now has to attend to clients in a frosty car park might be very glad of it.
"Of course, there are more women than men in the profession, so I'm going to offer one of the womens' vests too."
To win one of the gilets, watch the review here: https://www.youtube.com/watch?v=l84lRgEN1s4, then email: support@vetsurgeon.org with the answer to the following question:
On the medium heat setting, how long does the Ororo heated gilet stay warm?
First two correct answers out of the hat from those received by close of play next Wednesday (13th January) will get the gilets.
Arlo added: "Good luck, and a very happy New Year to you all. Let's hope we all get the vaccine soon.
"Oh, and if you enjoy the review, do subscribe on YouTube!"
The letter called on the UK government to ensure there is a duty on the state to have due regard for animal welfare in the development and implementation of policy, as Article 13 of the Lisbon Treaty sets out. Under the UK’s Animal Welfare Acts, accountability for the treatment of an animal focuses on the animal keeper, but not on the state.
The coordinated letter from the veterinary professions follows widespread media attention after a House of Commons debate, wherein MPs voted down an amendment tabled by Green MP Caroline Lucas to include the principles set out in Article 13, which also states animals are sentient, in the EU (Withdrawal) Bill. Since Article 13 has its origins in a treaty rather than a regulation, it did not qualify to automatically transfer into UK law as part of the EU (Withdrawal) Bill.
The signatories of the Daily Telegraph letter span all areas of veterinary work including small and large animal practice, research, government and academia as well as including former UK Deputy Chief Veterinary Officers, Officers of BVA specialist divisions and the Chief Veterinary Officer of SSPCA, amongst others.
BVA Senior Vice President Gudrun Ravetz has been leading BVA’s lobbying on this issue while BVA President John Fishwick recovers from a back operation. Gudrun said: "The public and professional response to the Article 13 vote was astonishing, but there was much misunderstanding borne from sensationalist headlines that suggested the MPs who voted the amendment down do not believe in animal sentience. The real crux of the debate got lost in this noise.
"BVA supports the principle of Article 13, since it not only recognises that animals are sentient, but importantly puts a duty on the state to have due regard for animal welfare in the development and implementation of policy."
For decades, animal welfare and public health issues have been reported at a variety of animal establishments. The Animal Protection Agency says that inconsistent inspection methods and a lack of objective guidelines have contributed to a situation it describes as unacceptable.
The new report, ‘Guidelines for Inspection of Companion and Commercial Animal Establishments', which was part-funded by the APA and is published in Frontiers in Veterinary Science1, offers guidelines for animal husbandry (including invertebrates, fishes, amphibians, reptiles, mammals and birds) and inspection protocols for a variety of commercial and non-commercial establishments.
Space for animals, responsible handover, facility layout and human health and safety are among the issues detailed in the publication, which also offers a scoring tool.
The APA says the publication is believed to be the most objective information resource of its kind anywhere in the world. It is freely accessible to anyone, whether for formal governmental, professional managerial or private use.
Lead author and biologist Clifford Warwick said: "Clear, definitive and objective guidance for animal care and facility inspection has long been needed to enable responsible authorities to oversee animal health and welfare with confidence, and hopefully many will welcome and find helpful this new report."
Co-author and veterinary expert Mike Jessop MRCVS said: "Animal welfare and improved public health are the clear winners from a standardised inspection system that is applicable to all companion animal establishments. Moving to a more objective and evidenced system of inspection is long overdue. The same principles and protocols are readily adaptable to encompass inspection of any animal holding facility."
Animal Protection Agency Director Elaine Toland said: "Britain has been called a 'nation of animal lovers', and many want the best for their pets. But there is also a nation of 'animal traders and keepers' out there who often aim to provide the most 'cost effective' and therefore lowest possible standards of space, habitat and general care that they can get away with, and that mindset needs to change."
Reference
Ceva Animal Health has introduced an improved version of Hepatosyl, its liver support supplement for horses.
Hepatosyl Plus for horses contains the same antioxidant ingredients as the original version but now also contains Silybin, the most active isomer of Silybum marianum (milk thistle)1.
According to Ceva, the addition of Silybin gives new Hepatosyl Plus a triple antioxidant approach to liver support to help neutralise free radicals within the liver. Free radicals are produced by hepatocyte mitochondria and cause oxidative damage to cell membranes, protein and DNA.
The company says Hepatosyl Plus's triple approach includes S-adenosylmethionine (SAMe), in a stable, pure and absorbable form, which is converted into the potent liver anti-oxidant glutathione and also helps to maintain bile flow; Vitamin E, which is well-known as a potent liver antioxidant, and Silybin, which works as an antioxidant by increasing cellular superoxide dismutase.
Hepatosyl Plus remains the only liver supplement to contain Vitamin K which is needed by the liver for the production of many essential clotting factors, such as factors II, VII, IX and X, making it ideally suited for pre and post anaesthetic liver support.
Ceva says an independent trial2 on horses with confirmed liver disease has demonstrated the benefits of Hepatosyl. Conducted by European Specialist in equine internal medicine Dr Tim Brazil, the trial involved seven horses of various ages and types. All animals were given Hepatosyl in addition to treatment with antimicrobials, corticosteroids, a low protein diet and vitamin B supplementation. Post SAMe supplementation tests revealed a notable reduction in raised liver enzymes, serum proteins and bile acids and the seven horses showed obvious improvements including better appetite, weight gain and demeanour.
For further product information contact Ceva Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG, telephone 01494 781510 or visit the website at http://www.ceva.uk.com/
References1 Flatland B (2003) Botanicals, Vitamins and Minerals and the Liver2 Brazil T (2007) S-adenosylmethionine liver support supplement trial in horses
Pfizer Animal Health and Central Veterinary Services are collaborating in a new venture to create a unified National Benchmarking Database open to all veterinary practices.
In what it says is an unprecedented move, Pfizer will integrate 15 years' worth of data from its Performance Index practice benchmarking service (formerly known as the Fort Dodge Index) with that of the Central Veterinary Services' Management Analysis Indices (MAI). These two benchmarking services have been in co-existence for a number of years, each using different databases. Combining the data from the participating practices within each benchmarking service will create a database of almost 300 practices, representing in excess of 10% of all UK companion animal and mixed practices. This, says the company, will provide a more accurate and relevant benchmarking of UK companion animal practice performance.
The first combined reports from this new National Database will be available in May providing a comprehensive analysis for the first quarter of 2012. For Performance Index practices, this will be available via a new web portal.
Participating practices will continue to access their reports and services independently via their respective portals for PI and MAI, but will benefit from the larger database providing greater accuracy, granularity and relevance of exactly who a practice chooses to benchmark itself against. This, in turn, should provide all participating practices with an even better understanding of both their critical success factors and where there are clear opportunities for growth. Pfizer says that as ever, practice data confidentiality will be guaranteed for all subscribing practices.
Ned Flaxman, Director Business Innovation, at Pfizer Animal Health said: "We have recognised that what veterinary practices really need is to be far more specific about who they benchmark themselves against. There is little relevance to a rural mixed practice in the Lake District employing 3 full time vets (FTVE) benchmarking themselves against a large 5 FTVE companion animal practice in the centre of Manchester - you are comparing apples and pears! My vision for creating the National Database was really to increase the business benefits of practice benchmarking and enable practices to compare apples with apples. With the new system, the large urban practice in Manchester should be able to compare its performance against other urban practices in the North of England employing 5FTVE!
"To ensure practices have accurate and relevant data from which to make informed decisions to grow and thrive in these turbulent conditions, the creation of a single national benchmarking database is the only sensible solution. Although we are effectively levelling the playing field by enabling other veterinary suppliers to offer benchmarking, we believe it is the right thing to do for veterinary practices and the market as a whole. For Pfizer Animal Health, the needs of our veterinary clients are the driving force for our business decisions, veterinary support services and product development."
Martin Barrow, Managing Director of Central Veterinary Services said: "We fully agree that a single benchmarking database is the right solution for the market. The creation of this National Database, open to all practices irrespective of their supplier, will provide the participants with unique tools to give them powerful insights for their practices' future continued success.
"MAI and the Performance Index have competed with each other for years and provided a very useful added value service for their respective subscribers but when we were approached to integrate the two databases, we immediately saw the bigger picture and recognised the significant benefits this could bring to a wider audience of UK veterinary practices.
"The national database uses open standards for data collection and data is accepted from all practices irrespective of which practice management system they use. We believe it is the right thing to do for veterinary practices and brings significant benefits to the whole veterinary profession."
Practices are urged to subscribe to the PI or MAI services either independently or through one of their practice development partners. Although run from a common database each service will continue to be provided with its own unique features.
For further information on Performance Index practices should contact their Pfizer Account Manager, email Pfizer at Vetsupportplusuk@pfizer.com.
For further information on MAI, practices should contact Central Veterinary Services at mai@centralvet.com, or telephone 01359 245310
The award was due to be presented at the association's annual shindig in March, which was cancelled due to the coronavirus pandemic.
VMA Awards chair, Claire Edmunds, said: “This years’ winners will still get their moment of glory on stage next March at the rescheduled event. We can also announce that the event is likely to include some additional categories to recognise campaigns and initiatives undertaken during the COVID-19 pandemic.”
Carlos Michelsen, managing director of award sponsor, CM Research, added: "Thanks to the continued success of Cytopoint, Zoetis achieved highly commended status. But it was Elanco that came in as award winners, with their novel veterinary pharmaceutical product Galliprant taking the crown. Congratulations to Elanco!"
Rebecca Bryant, Elanco’s marketing manager for Pet Health Therapeutics (pictured right), said “Elanco is delighted to be recognised by the veterinary community with this prestigious award for Galliprant. The UK team is proud to be part of the launch of this innovative, first-in-class product which has already enriched the lives of thousands of pet owners and their dogs living with osteoarthritis. It’s fantastic to hear from vets that managing OA with Galliprant has already made a positive impact on their practices.”
Zoetis product manager, Allison Henry said: “We are very proud to come such close second in this award category as it is a true testament to the lasting innovation Cytopoint has brought to our industry, customers and pets. At Zoetis, we always strive to develop innovative new medicines for the veterinary industry and we are thrilled to see how Cytopoint has done just that.”
To carry out the practice of veterinary medicine, a veterinary practitioner must be registered in the jurisdiction in which they are practising ie a veterinary practitioner who practises veterinary medicine in the Republic of Ireland must be registered with the VCI; likewise, a veterinary surgeon who practises in Northern Ireland, England, Scotland or Wales, must be registered with the RCVS.
EU Directive 2005/36EC enables a veterinary surgeon who is lawfully established and registered in an EU member state to provide services on a temporary and occasional basis in another member state. This service allows registered veterinary surgeons to occasionally practise in other countries in the European Union for short periods, up to a maximum of 30 days per year.
From 1st January 2021, the Directive will no longer apply to veterinary practitioners from the Republic of Ireland who may want to provide veterinary services in the UK and that they would therefore need to be registered with the RCVS even if provision of these services is temporary and occasional.
However, in October 2019 the Presidents of the RCVS and the VCI signed a Mutual Qualification Recognition Agreement. The agreement means that the degree in veterinary medicine from University College Dublin can be recognised by the RCVS, and the current eight RCVS-recognised UK veterinary medicine degrees can be recognised by the VCI. The recognised qualifications are accepted as the basis for registration to practise veterinary surgery by the RCVS in the United Kingdom and veterinary medicine by the VCI in the Republic of Ireland.
The VCI and the RCVS emphasised that regardless of whether a trade agreement has been signed between the EU and the UK by 1 January 2021, this will have no bearing on the Mutual Qualification Recognition Agreement currently in place.
Niamh Muldoon, CEO and Registrar of the Veterinary Council of Ireland, said: “This historic agreement will enable graduates of Irish and UK veterinary schools to continue to seek to practise in the other country when they wish. We look forward to continuing to collaborate with our colleagues in the RCVS in the future for the benefit of the profession in both countries.”
Mandisa Greene, President of the Royal College of Veterinary Surgeons said: “I am very glad to be able to affirm our continuing working partnership with our friends and colleagues in the Republic of Ireland. We know that veterinary surgeons based both in Northern Ireland and the Republic of Ireland have clients and undertake work on both sides of the border, and this Mutual Recognition Agreement will help to ensure that UK and Ireland-qualified veterinary surgeons are able to register in each other’s jurisdictions where required. I too look forward to continuing to work closely with the VCI both on a bilateral basis, and via pan-European institutions such as the Federation of Veterinarians of Europe.”
Step 1: Clean with Oticare, a non-irritating, alcohol-free ceruminolytic ear cleaner formulated to keep ears hygienically clean and restore the normal microbiological balance of the ear canal. The product contains soothing essential oils and propylene glycol to moisturise the lining of the ear canal. It also contains a low concentration of lactic acid and salicylic acid.
Step 2: Treat with Aurimic (polymyxin B, miconazole and prednisolone acetate), which tackles the most common causes of otitis externa; e.g. Staphylococcus spp. and Malassezia. Animalcare says the proven synergistic effects of polymyxin B and miconazole1 allow the reduction of antibiotic concentration and help to minimise the probability of resistance.
Step 3: Prevent with new Oticurant, which Animalcare says is a completely new concept for maintaining healthy ears. Oticurant contains lactic acid to lower the pH, kaolin and lactose to absorb any additional moisture, and special sugars to prevent bacterial adherence to the skin in the ear canal. Oticurant is presented as an odourless mixture of fine powder in single dose sachets.
Tamsin Day, Veterinary Advisor at Animalcare, said: "This is a unique three step approach which we believe will give veterinary professionals more confidence in treating first line ear problems. The Super-earo’s represent a range of three products that together cover cleaning, treatment and prevention. Pet owners will find them easy to administer which will also help to keep these owners compliant to their treatment schedule."
For more information on the Super-earo’s contact your Animalcare representative or visit www.superearos.com
Dermipred is available in two pack sizes – 10mg and 20mg - to treat a range of dog sizes. Both presentations feature a four-way break tablet to enable accurate and flexible dosing, and the product is flavoured to aid compliance. The product is blister-packed for easy dispensing.
Ceva has produced an accompanying electronic brochure on CAD management options. It includes: understanding and decoding CAD, diagnosis and management of the condition.
Allison Henry, Dermipred product manager at Ceva said: "CAD affects approximately a million dogs in the UK, with 70% of all owners believing that the condition has had an impact on their dogs’ quality of life1.
"The addition of Dermipred to Ceva’s extensive dermatology range will provide veterinary professionals with even more treatment options for the management of pruritus and skin inflammation in CAD cases."
To support the launch of Dermipred, Ceva will be running an offer on its dermatology range of products: every client purchasing a box of each Dermipred presentation and a bottle of Modulis will receive one box of Dermipred 10mg, one bottle of the same Modulis size and one bottle of Douxo Calm shampoo and mousse free.
For further information, contact your local Ceva account manager or email cevauk@ceva.com.
PhotonUVC Vet is a non-contact treatment which emits low dose ultraviolet C light at a targeted area.
Photon Therapeutics says the device kills bacteria, viruses, fungi and other infecting organisms while being safe to host tissues.
Other claimed benefits of the device are that it avoids client compliance issues associated with eye-drops, it eliminates the need for antibiotic eye drops, and it is very simple to learn how to use.
The device costs £4,995.
To explain more about The PhotonUVC Vet, Dr. Simon Dean. MBChB, MSc, FRANZCO, FBCLA Chief Scientific Officer at Photon Therapeutics, and Dr. Mark Leddy BVSc, MBA, CEO, will be delivering a CPD presentation at the Exhibitor Showcase Theatre 3: "5 Amazing Seconds – A New Transformative Treatment for Corneal Infections", on Thursday 14th November at 3pm.
There is also a launch event reception at the stand from 16.15 to 18.15 on Thursday 14 November.
https://photon-therapeutics.com/
The RCVS Disciplinary Committee has directed that the name of a Berkshire-based veterinary surgeon, previously convicted of four offences under the Animal Welfare Act 2006, should be removed from the RCVS Register of Veterinary Surgeons.
Dr Ohene-Gyan was convicted at Reading Magistrates Court on 13 June 2012 of offences involving causing unnecessary suffering to three dogs and a cat that he had treated whilst working at Woosehill Vets, Wokingham, between February and October 2011. These offences related to failing to provide adequate or appropriate veterinary care or treatment, or failure to investigate and address an animal's poor condition. He was sentenced to 21 weeks' imprisonment concurrently for each offence.
Dr Ohene-Gyan did not attend the one-day Disciplinary Committee hearing and was not represented, although College records showed that he was aware of the dates of the hearing, and had had opportunity to apply for an adjournment. In the absence of any known good reason for Dr Ohene-Gyan's non-attendance, the Committee concluded that it was in the interests of justice that the hearing go ahead.
In considering whether the Respondent's convictions made him unfit to practise as a veterinary surgeon, the Committee depended on the findings of the District Judge and the remarks she had made when sentencing. "I found as a matter of fact that some of your actions were taken simply to run up a bill for the owners of pets," she had said. "You were in a position of special responsibility, trusted by the owners of the animals to treat them appropriately and to alleviate their suffering. You ignored advice from staff. Several animals were affected by your cruel disregard of their welfare. Some of the cruelty arose due to your incompetence. You have demonstrated that you are not fit to be trusted with the care of animals."
The Disciplinary Committee Chairman, Professor Peter Lees, speaking on behalf of the Committee, said: "The Respondent's actions, motivated by financial gain, caused serious actual injury to the four animals over a prolonged period of time. Clients are entitled to expect that veterinary surgeons will treat animals in their care humanely and with respect, and make animal welfare their first priority. The Committee considers that the care described in the District Judge's findings demonstrated a total disregard for the professional responsibilities of a veterinary surgeon."
The Committee concluded that the removal of Dr Ohene-Gyan's name from the Register was the only appropriate and proportionate sanction in this case in order to protect the welfare of animals, maintain public confidence in the profession and uphold proper standards of conduct, and it directed the Registrar to do so.
Simon Wootton, Northern European Region CAG Marketing Manager at Idexx said: "It is widely accepted that 1 in 3 cats and 1 in 10 dogs will develop CKD. The adoption by IRIS of the Idexx SDMA™ renal function test is testament to its benefits, and should give vets much more time to intervene and prescribe an appropriate course of action to help improve longevity and quality of life in CKD patients."
Idexx has produced two new wall-charts for practices, intended to assist with the diagnosis, staging and treatment of CKD in dogs and cats. They are being distributed to all practices in the UK, and can also be downloaded from the Idexx website – www.idexx.eu or ordered from Idexx by ringing 00800 1234 33 99.
Massimo (pictured left) qualified from Bologna Vet School in 1990 and spent two decades working as a specialist in veterinary neurology in Italy and Germany, following a three-year residency in neurology and neurosurgery at Bern in Switzerland.He has also spent almost 20 years lecturing at universities in Italy, including ten years as head of neurosurgery and advanced neurology diagnostics.
He said: "During my career I’ve spent short amounts of time in the UK and once I was aware of the opportunity to work with Northwest Veterinary Specialists, I jumped at the chance to move here.
"It has a fantastic reputation in providing the very best care to pets, and the recent investment in state-of-the-art facilities means we can offer the very best service to patients.
"I have a particular interest in continually improving our work around brain and spinal surgery and biopsies, and will be further researching technology and techniques to support treatment of epilepsy in pets."
Luca, who is currently a member of the Examinations Committee of the European College of Veterinary Neurology, also qualified in Italy (in 2007) at the University of Perugia, before moving to England where he completed his internship program in small animal medicine & surgery in 2009. He gained residency at a multi disciplinary referral hospital in the UK and was awarded the European College of Veterinary Neurology (ECVN) in 2012.
Luca has authored scientific papers in peer reviewed international journals and he has also been a reviewer for the Journal of Small Animal Practice and for the BMC Veterinary Research.
He said: "We’ll be focusing on changing the way we do neurosurgery to ensure the pets referred to us receive the very best treatment for their condition.
"We often see patients with intervertebral disc disease and epilepsy, and I’m looking to increase work around my main interests, including surgery of the central nervous system and epilepsy."
Liz Cousins, hospital manager at Northwest Veterinary Specialists said: "This year we’ve been making significant investment in our facilities and people, so it’s fantastic to be able to attract two experienced neurology specialists in Luca and Massimo,” said Liz Cousins, hospital manager at Northwest Veterinary Specialists.
"Luca and Massimo’s appointments clearly demonstrate our emphasis on creating teams of experienced and extremely knowledgeable specialists across the centre."
The traditional NVQ 'portfolio' system for student veterinary nurses could be phased out from next summer, under draft proposals from the Royal College of Veterinary Surgeons Awarding Body, which has responsibility for the delivery of VN qualifications.
Proposals include an initial year of full-time college study, during which the student does not need to be employed in a Training Practice (TP), the introduction of compulsory farm animal work experience, the phasing out of the separate Equine Veterinary Nursing qualification and a reduction in practice-based assessment.
The catalyst for reviewing the VN qualification came from Ofqual's plans to introduce the new Qualifications and Credit Framework (QCF) from summer next year, which effectively scraps the NVQ in its current form. This gave the RCVS Awarding Body an excellent opportunity to reconsider work-based training for VNs in order to improve its effectiveness and efficiency.
The Awarding Body's proposals, on which comments are invited, aim to reduce bureaucracy for those involved with VN training, increase the number of practices able to take part and improve accessibility of training, ultimately increasing the number of qualified VNs available to the profession.
Under the new proposals, VN work-based training would be a two-year, 70-credit Level 3 qualification, equivalent to 700 hours' learning. The first year of this qualification could be delivered either as a full-time college course, or as a part-time day-release over two years (extending the complete training to three years). The first year would incorporate 25 days' work placement, including small animal, equine and farm animal environments - the first time a compulsory farm animal component has been introduced. This first year of the course could be directly accessed by school leavers, as there is no requirement for them to be employed in a practice.
Students would be employed in a Training Practice for the second 'clinical' year (or third year for part-time students). An online log of practical experience, similar to the Professional Development Phase for new veterinary graduates, would replace the current portfolio, with a more comprehensive end-of-year practical exam. There would no longer be a requirement for practice-based assessors, although students would still need to be supported by an experienced clinical mentor, a role many current assessors may assume.
The economic feasibility of Equine Veterinary Nurse (EVN) training was also considered, with the conclusion that a broader-based primary qualification, with all students carrying out work experience in a range of practice types, was more sustainable.
The number of training practices has long been recognised as a limiting factor in the UK's capacity to train VNs. In addition to standard TPs, proposals have therefore been made for Auxiliary TPs (ATPs). ATPs would be able to employ and train VN students even if they do not have the facilities to provide all of the work experience required: a formal agreement to allow students to fill the gaps at another practice would be in place.
Finally, the proposals include a beefed up range of post-registration education options, allowing Registered Veterinary Nurses to develop, and be recognised, in their own areas of interest. This would help to create a career ladder for RVNs and assist in their retention within the profession.
"The proposals have been developed following a period of consultation with those involved with the delivery of VN training, and with employers," says Jacqui Molyneux, RCVS Council Member and Chairman of the VN Awarding Body.
"Feedback suggests that the current syllabus and training provides competent nurses who are highly regarded within the profession, but that training is overly burdensome for the practices involved. This, coupled with a recognised shortage of both Training Practices and qualified VNs, meant it was appropriate to think more creatively about how the qualification could be delivered. We hope that the draft proposals will be welcomed by both the veterinary nursing and veterinary professions, and would urge people involved to let us know what they think."
The proposals are available on RCVSonline (www.rcvs.org.uk/latestnews ) - please email your comments to Miss Jane Dawson, Project Consultant (jkhdawson@aol.com), by 31 October 2009. It is appreciated that this is a short deadline, however, the time-frame of the QCF is driving development, as is the need to allow colleges and training providers the maximum possible time to develop the new training structure for 2010/11 delivery.
Eskimo, a reindeer at Edinburgh Zoo has received life-saving surgery just in time for Christmas, making him the first reindeer in history to receive keyhole surgery.
Vet Romain Pizzi successfully removed one of Eskimo's testes, which had been lodged in its abdomen since birth, using specialist surgical instruments donated to the zoo by one of Ark Surgical's strategic partners Surgical Innovations.
The zoo was worried that the retained testicle may have been developing into a tumour giving off abnormal hormones, and that this could become life-threatening. Thankfully, zoo surgeons found that the retained testicle, although abnormally sized, had not yet developed a tumour.
It is thought that the abnormal testicle was affecting Eskimo's production and flow of testosterone and, as a result, he was showing submissive behaviour and being bullied by the other male reindeer in the herd. He had also started to show some abnormal and delayed antler growth and development. Removing the testicle will halt any abnormal hormone production so hopefully Eskimo will return to full vigour just in time for Christmas.
Gavin O'Brien, Director at Ark Surgical said: "We were only too happy to help when Romain mentioned the challenging operation faced by Eskimo and in the season of goodwill we approached Surgical Innovations who kindly donated the instruments for this pioneering surgery."
Although laparoscopic surgery is routine in humans, the standard procedure in animals is still open abdominal surgery. Open abdominal surgery is 20 years behind human medical advances and has a number of negative factors on animals such as more post-operative pain, slower recovery and a higher risk of post-operative complications and infections.
Romain, a veterinary surgeon for the Royal Zoological Society of Scotland, based at Edinburgh Zoo, said: "Laparoscopic surgery is still very uncommon in veterinary medicine, even amongst common species such as dogs, cats and horses, so for keyhole surgery to be carried out on a reindeer shows a great advancement in veterinary surgery."
It is estimated that nearly one out of every two households in the UK are pet owners. Veterinary surgeons perform on average 600,000 open abdominal procedures annually but it is believed that less than 1% of vets currently practice laparoscopic surgery.
Romain believes that with the right instrumentation available through innovative companies such as Ark Surgical, UK vets now have more opportunity than ever to introduce laparoscopic techniques as part of their operating procedures.
Romain said: "This procedure was only really possible thanks to a cutting-edge designed retractor which we were able to use in this case. Ironically although a reindeer is a reasonably large animal, due to their unique anatomy and massive four chambered stomach that takes up most of the space in the abdomen, there is a very limited internal operating space. For this reason the operation was much more difficult than in a human, or in a dog, where there is more space to work, despite their smaller size."
"We were especially pleased with how quickly Eskimo recovered after surgery, he was standing and happily eating lichen again within 10 minutes of recovery from anaesthesia. He hardly seemed to notice he had even had surgery, although he was still slightly groggy from the anaesthesia. This would simply not have been possible with traditional open abdominal surgery, as the long wound would have been much more painful and debilitating."
The minimally invasive nature of laparoscopic surgery means there are numerous benefits for animals such as a reduction in post-operative pain, a faster recovery and reduced post-operative care. It also has a decreased risk of infection after surgery and a lower risk of any wound complications.
For veterinary surgeons laparoscopic surgery can offer better visualisation of the operated area, allowing them to be more precise and reach areas that are difficult to see in open surgery such as the liver and pelvic canal.
Romain carries out laparoscopic operations on dogs, cats and exotic pets at his own veterinary practice Inglis Veterinary Centre (Scotland) and has pioneered several new laparoscopic techniques.
He said: "Laparoscopic surgery has so many benefits for the animal, the veterinary surgeons and the zoo, so there is no reason why it should not be more common practice within veterinary surgery. I hope Eskimo's experience helps raise its profile and encourage more veterinary surgeons to look in to it as a standard surgical procedure."
Ark Surgical offers a wide range of laparoscopy instruments and peripherals to vets across the UK and to suit all budgets. The company says it is already working with many of the UK's leading vets and agencies such as the Royal Zoological Society of Scotland, as well as the UK foremost laparoscopic medical device manufacturer Surgical Innovations, to be at the forefront of veterinary laparoscopic surgery
For more information on animal laparoscopic surgery contact Ark Surgical on 01732 862882 or http://www.arksurgical.co.uk/
Eleven members of staff at the Royal College of Veterinary Surgeons are growing moustaches this month in support of the Movember Challenge, a campaign which raises funds to help combat prostate cancer.
Simon Wiklund, Advisory Manager and instigator of the College's participation in Movember 2010, said: "Visitors to the College over the next few weeks shouldn't be alarmed if some members of staff begin to resemble a Village People tribute band. I suggested this to the chaps last week, and was delighted so many were willing to look daft for such a good cause."
According to the Movember website, the aim is simple: "One man dies from prostate cancer every day in the UK. Movember challenges men to change their appearance and the face of men's health by growing a moustache. All MoBros should be clean shaven on 1 Movember and then grow a moustache for the entire month. The moustache becomes the ribbon for men's health, the means by which awareness and funds are raised for cancers that affect men."
The RCVS team - 'All 'Taches Great and Small' - comprises at least one member of every department in the College, so whilst the team as a whole will be raising as much money as it can, the College says it expects interdepartmental competition to get "quite hairy".
"In spite of ourselves, reputations are at stake here," admits Simon. "We're a mixed-ability team, so it will be interesting to see who sports the best tache at the end of Movember. This is no trivial hirsute."
Lending his support to the team's efforts, and off to something of a head start in the facial forestry department, is RCVS President Peter Jinman. He said: "I'm impressed that so many of the gents on the staff have taken it upon themselves to support The Prostate Cancer Charity in this way. If it's true that eight out ten chaps really do prefer whiskers, they should raise a decent amount of money."
Anyone wishing to support the All Taches Great & Small team in their bristling endeavours should please visit their fundraising pages (via www.rcvs.org.uk/movember). Donations can be made to individual MoBros, or to the team as a whole.
Norbrook Laboratories has launched a long-acting cattle bolus which it says will reduce the risk of Milk Fever.
According to the company, Calcitrace D3 is the first and only long-acting bolus to offer slow and fast releasing calcium to provide sustained calcium levels for 48 to 72 hours. In addition, Calcitrace D3 provides Magnesium, Phosphate and Vitamin D3 making it the most comprehensive bolus available.
Calcitrace D3 is smooth gelatin coated bolus with a rounded tip designed for easier administration. Norbrook says it is smaller than other boluses making it less likely to cause trauma on the orpharynx during administration.
Dr Barry McInerney, Norbrook's GB Veterinary Advisor said: "Milk Fever is a common metabolic disorder in dairy cattle which generally affects older, high producing cows and is caused by a rapid decrease in calcium concentrations in the blood just before calving. It is estimated that 3-10% of cows are affected by Milk Fever with a cost of more than £200 per incident so it is crucial that farmers and vets reduce the risk as effectively as possible.
"Norbrook's new Calcitrace D3 bolus which should be administered just before calving, provides higher calcium blood levels during the critical 12 - 48 hour post calving period and provides sustained increased levels for well beyond 48 hours. With the addition of Magnesium, Phosphate and Vitamin D3, Calcitrace D3 provides additional protection against Milk Fever."
Andrew Hillan MVB MRCVS, Director of Veterinary Sciences at Norbrook, led the development of Calcitrace D3. He said: "The launch of Calcitrace D3 is another illustration of the very high quality of technical expertise that exists within our research and development department and underlines Norbrook's commitment to developing high quality and innovative products. It comes from a strong and exciting pipeline of new products which we will bring to the market over the next couple of years."